Northwest Biotherapeutics, Inc. (NWBO)
0.1696
0.00 (0.00%)
USD |
OTCM |
Sep 04, 16:00
Northwest Biotherapeutics Shareholders Equity (Quarterly) : -34.70M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -34.70M |
| March 31, 2026 | -37.98M |
| December 31, 2025 | -47.49M |
| September 30, 2025 | -95.17M |
| June 30, 2025 | -86.56M |
| March 31, 2025 | -84.76M |
| December 31, 2024 | -78.90M |
| September 30, 2024 | -64.16M |
| June 30, 2024 | -57.66M |
| March 31, 2024 | -53.39M |
| December 31, 2023 | -46.98M |
| September 30, 2023 | -37.37M |
| June 30, 2023 | -35.57M |
| March 31, 2023 | -32.15M |
| December 31, 2022 | -104.96M |
| September 30, 2022 | -95.02M |
| June 30, 2022 | -91.59M |
| March 31, 2022 | -120.45M |
| December 31, 2021 | -123.91M |
| September 30, 2021 | -301.65M |
| June 30, 2021 | -349.76M |
| March 31, 2021 | -353.12M |
| December 31, 2020 | -362.87M |
| September 30, 2020 | -212.40M |
| June 30, 2020 | -81.29M |
| Date | Value |
|---|---|
| March 31, 2020 | -34.98M |
| December 31, 2019 | -45.04M |
| September 30, 2019 | -54.52M |
| June 30, 2019 | -53.00M |
| March 31, 2019 | -58.49M |
| December 31, 2018 | |
| September 30, 2018 | -47.13M |
| June 30, 2018 | -63.79M |
| March 31, 2018 | -62.92M |
| December 31, 2017 | -47.29M |
| September 30, 2017 | -42.83M |
| June 30, 2017 | -35.24M |
| March 31, 2017 | -36.64M |
| December 31, 2016 | -26.50M |
| September 30, 2016 | -5.022M |
| June 30, 2016 | -18.97M |
| March 31, 2016 | -6.193M |
| December 31, 2015 | -4.676M |
| September 30, 2015 | -57.36M |
| June 30, 2015 | -76.17M |
| March 31, 2015 | -70.70M |
| December 31, 2014 | -35.03M |
| September 30, 2014 | -31.22M |
| June 30, 2014 | -29.75M |
| March 31, 2014 | -31.06M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
| Savara, Inc. | 143.66M |
| Vericel Corp. | 370.04M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 76.02M |
| Total Liabilities (Quarterly) | 110.72M |
| Debt to Equity Ratio | -1.818 |
| Current Ratio | 0.0351 |
| Net Debt Paydown Yield | 0.38% |